Visaka Industries Rating ‘Buy’; A beat across all parameters in Q3FY21

By: |
February 8, 2021 3:45 AM

FY21/22 PAT up 25/14.5%; RoCEs to rise to 17.8% by FY22e; TP revised to Rs 705

VSKI reported its Q3FY21 revenues at 2.81 bn, up 16.3% y-o-y, led by sharp rise in Vnext revenues (up 19% y-o-y) and robust demand for ACS (+29% y-o-y).VSKI reported its Q3FY21 revenues at 2.81 bn, up 16.3% y-o-y, led by sharp rise in Vnext revenues (up 19% y-o-y) and robust demand for ACS (+29% y-o-y).

Visaka Industries (VSKI) reported a strong beat across parameters while reporting a PAT of Rs 231 mn , up 275% y-o-y. The performance was largely driven by: a) sharp rise in Vnext (FCB) revenues (up 19% y-o-y) driving significant improvement in its segmental Ebitda margin to ~15% (all-time high) on the back of operating leverage and y-o-y decline in input costs; and b) sustained strong operational performance in asbestos cement sheet (ACS) segment led by double-digit revenue growth and firm pricing.

Mgmt guidance remained upbeat for FY22: 1) double-digit volume growth and firm margin in ACS and Vnext segment; 2) synthetic yarn segment to return to normalcy; 3) company is likely to become a net cash company next year; and 5) RoCEs are likely to gain further traction. Maintain Buy.

Sustained demand/pricing tailwinds in ACS/FCB aid outperformance: VSKI reported its Q3FY21 revenues at 2.81 bn, up 16.3% y-o-y, led by sharp rise in Vnext revenues (up 19% y-o-y) and robust demand for ACS (+29% y-o-y). Synthetic yarn revenues too recovered sharply reaching 85% of last year’s revenues. Ebitda margin came in at 14.9%, up 600bps y-o-y. The beat was largely driven by strong Ebitda margin improvement in both ACS and Vnext. Synthetic yarn segment margin too recovered sharply q-o-q to 9%.

Valuation and outlook: Factoring in the Q3FY21 performance, we increase FY21e/FY22e PAT estimates by 24.9%/ 14.5% respectively. We now expect revenue and PAT CAGRs of 9.5% and 43.8% over FY20-FY22E. Strong FCF generation over FY21E-FY22E despite incremental capex for new Vnext plant would help improve RoCEs from 9.7% in FY20 to 17.8% in FY22E. Maintain Buy with a revised TP of Rs 705 (earlier: Rs 617), implying P/E multiple of 12x FY22E earnings.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1NSE halts trading for 4 hours over tech glitch, market hours extended
2India’s mustard output set to hit record 10 million tonne this year
3Sebi moots introduction of accredited investor concept; floats consultation paper